| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734127 | Journal of Surgical Research | 2017 | 30 Pages |
Abstract
In this nonrandomized, nonblinded, observational trial, patients in the TXA group displayed prolonged CTs and clot fibrinogen (FIBTEM A5-30) after sternotomy, decreased clot strength (EXTEM) after CPB/surgery, and acute thrombocytopenia after protamine-sternal closure. There was no significant decrease in clot lysis, questioning the need for TXA in this medium-risk group.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Rajiv MD, MCh, Hayley L. PhD, Samuel MBBS(c), Geoffrey P. PhD, FAHA,